Journal article
Mpox in persons with advanced HIV infection: a global case series
- Abstract:
-
Background: People living with HIV have accounted for 38–50% of those affected in the 2022 multicountry mpox outbreak. Most reported cases were in people who had high CD4 cell counts and similar outcomes to those without HIV. Emerging data suggest worse clinical outcomes and higher mortality in people with more advanced HIV. We describe the clinical characteristics and outcomes of mpox in a cohort of people with HIV and low CD4 cell counts (CD4 <350 cells per mm3).
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 546.5KB, Terms of use)
-
- Publisher copy:
- 10.1016/S0140-6736(23)00273-8
- Publisher:
- Elsevier
- Journal:
- Lancet More from this journal
- Volume:
- 401
- Issue:
- 10380
- Pages:
- 939-949
- Publication date:
- 2023-02-21
- Acceptance date:
- 2023-02-02
- DOI:
- EISSN:
-
1474-547X
- ISSN:
-
0140-6736
- Language:
-
English
- Keywords:
- Pubs id:
-
1327425
- Local pid:
-
pubs:1327425
- Deposit date:
-
2023-02-06
Terms of use
- Copyright holder:
- Elsevier
- Copyright date:
- 2023
- Rights statement:
- © 2023 Elsevier Ltd. All rights reserved.
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/S0140-6736(23)00273-8
If you are the owner of this record, you can report an update to it here: Report update to this record